Biotech Values

[jbog]

I'm sure EOLS will manage the company completely different than what we're used too seeing.

We have to remember that EOLS is primarily owned and has to perform by the direction of Alphaeon Corporation which still retains > 60% of the stock.

Most of Alphaeons dispositions have been transactions, maybe even arms length transfers, to satisfy debt. It doesn't seem like Alpheon wants to be diluted but time will tell.